Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1314080-45-9

1314080-45-9

Post Buying Request

1314080-45-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • Piperidin1-yl(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone

    Cas No: 1314080-45-9

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

1314080-45-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1314080-45-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,0,8 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1314080-45:
(9*1)+(8*3)+(7*1)+(6*4)+(5*0)+(4*8)+(3*0)+(2*4)+(1*5)=109
109 % 10 = 9
So 1314080-45-9 is a valid CAS Registry Number.

1314080-45-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name piperidin-1-yl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]methanone

1.2 Other means of identification

Product number -
Other names piperidin-1-yl(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1314080-45-9 SDS

1314080-45-9Downstream Products

1314080-45-9Relevant articles and documents

Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: Part 1

Matasi, Julius J.,Brumfield, Stephanie,Tulshian, Deen,Czarnecki, Michael,Greenlee, William,Garlisi, Charles G.,Qiu, Hongchen,Devito, Kristine,Chen, Shu-Cheng,Sun, Youngliang,Bertorelli, Rosalia,Geiss, William,Le, Van-Duc,Martin, Gregory S.,Vellekoop, Samuel A.,Haber, James,Allard, Melissa L.

, p. 3805 - 3808 (2011/07/31)

Structure-activity relationship (SAR) efforts around our initial lead compound 1 led to the identification of potent P2X7 receptor antagonists with improved pharmacokinetic profiles. These compounds were potent and selective at the P2X7 receptor in both human and rodent. Compound (entry 31) exhibited oral efficacy in the rat MIA and CCI pain models.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1314080-45-9